Manitoba Renal Program

Manitoba Renal Program

Manitoba Renal Program (MRP) coordinates and delivers kidney health care services for adults in Manitoba and promotes kidney health through education. The program is an interdisciplinary team of health-care professionals working together alongside hospitals, regional health authorities, governments and communities to deliver the highest quality kidney health care and education.

Manitoba Renal Program (formerly Manitoba Provincial Dialysis Program) was mandated in 1998 by Manitoba Health under the umbrella of the Winnipeg Regional Health Authority (WRHA) to provide care for all patients receiving dialysis therapies in Manitoba.

Mandate

  • Provide adult clinical care and education regarding all aspects of acute and chronic renal or kidney disease
  • Plan and monitor province-wide kidney care services
  • Develop province-wide clinical standards and guidelines
  • Measure and report on patient and system outcomes
  • Support renal staff and patients through education and teaching

Goals

  • Deliver high quality kidney health care services to Manitobans
  • Improve early diagnosis and treatment of chronic kidney disease
  • Promote prevention of chronic kidney disease through education

5A70 Seven Oaks General Hospital
2300 McPhillips Street
Winnipeg, Manitoba, Canada
R2V 3M3
Phone: 204-632-3607
Fax: 204-632-6168
Email: kidneyhealth@wrha.mb.ca

For a complete listing of dialysis centres in Manitoba visit our locations page.

If you are visiting Manitoba from another province or country, and want to make arrangements to receive dialysis treatments during your visit, please visit our Out of Province Patients page.

Manitoba Renal Program Regional Program Leadership:

Dr. Mauro Verrelli
Medical Director, Manitoba Renal Program
Associate Head, Section of Nephrology, University of Manitoba

Dr. Claudio Rigatto
Section Head, Section of Nephrology, University of Manitoba
Associate Medical Director, Manitoba Renal Program

Betty Lou Burke
Program Director, Manitoba Renal Program

Albert Mota
Administrative Director – Manitoba Renal Program (and Corporate, Community Health Services)

Executive Leadership

Krista Williams – Chief Health Operations – WRHA

Dr. Ainslie Mihalchuk – Interim Chief Medical Officer – WRHA

MRP Program Team:

Doug Franklin
Manager, Renal Technology

April Bertrand
Manager Peritoneal Dialysis Community Care & Kidney Health Outreach

Amie Lesyk
Communications Specialist

Nickie Cool
Transition Coordinator

Glenda Peebles
Aboriginal Liaison Coordinator

Krista Stewart & Eric Garcia
Fitness & Wellness Coordinators

Julie Lorenz, Angie Wieler
Regional Educators

Sharon Edmundson & Janelle Peterson
electronic Kidney Health Record

Gacheri Dyck
Quality Improvement Officer

Dr. Lori Wazny & Dr. Christine Davis
Pharmaceutical Care Coordinators

Hospital Site Leadership & Teams:

Health Sciences Centre & Local Renal Health Centres Program

Dr. Joe Bueti
Medical Director, HSC Renal Program

Dr. Herman Lam
Medical Director, Central Dialysis Unit

Dr. Don Allan
Medical Director, Sherbrook Centre Dialysis Unit

Dr. James Zacharias
Medical Director, Manitoba Local Renal Health Centres
Medical Director, Home Hemodialysis, HSC

Jennifer Cumpsty
Director of Patient Services, HSC Renal Program

Odete Williams
Manager, Patient Care
Dialysis

Sandra Lang-Donald
Manager, Patient Care
Dialysis

Rob Gibson
Manager, Patient Care
Kidney Health Clinic, Local Renal Health Centres, Home Hemodialysis

Seven Oaks General Hospital

Dr. Sean Armstrong
Medical Director, SOGH Renal Program

Dr. Andrea Mazurat
Medical Director, SOGH Hemodialysis

Dr. Paul Komenda
Medical Director, Home Hemodialysis

Dr. Sara Dunsmore
Medical Director, Peritoneal Dialysis & Renal Clinic

Henni Dyck
Program Director, SOGH Renal Program

Harjinder Brar
Patient Care Team Manager, Hemodialysis

Lori Schellenberg
Patient Care Team Manager, Home Hemodialysis, Renal Health Clinic, Peritoneal Dialysis

St. Boniface Hospital

Dr. Mauro Verrelli
Medical Director, SBH Renal Program
Medical Director, Peritoneal Dialysis

Dr. Justin Walters
Medical Director, Hemodialysis

Jason Hillier
Program Director, Renal & Palliative Care

Belinda Herner
Patient Care Manager, Dialysis

Heloise Buhler
Program Team Manager, Palliative Care and Peritoneal Dialysis

Brandon Regional Health Centre

Dr. Barry Riche
Medical Director, BHRC Renal Health Program

Kim Wallis
Program Manager, Renal Unit

For more information on the additional 16 Local Renal Health Centres click here.

MRP Year in Review 2017-2018


 

MRP Year in Review 2015-2016

MRP Year in Review 2012-2013

Manitoba Renal Project is actively involved in projects and initiatives that support our goals and improve our programs and services.

Read about some of our projects here:

IKHealth

Can-SOLVE CKD Network

FINISHED Project

Electronic Kidney Health Record

eGFR Pathways for Health-Care Providers

Published research with MRP staff as contributing authors:

2017-2018

Hingwala J, Kumra R. Reducing medical administration errors in the dialysis unit. Creation and redesign of process maps, dialysis flow and treatment sheets, and standardized tools for dialysis staff.

Hingwala J. A3 implementation for staff initiatives. Educating and training nephrology staff on A3 worksheet.

Basaraba G, Lyndsay A, Bueti G, Hingwala J. Dialysis medication requisitions. Creation and implementation of specialized medication requisitions for chronic dialysis patients when they are admitted to hospital.

Hingwala J. Improve clinic patient flow and efficiency. Create process mapping and value stream mapping to reduce redundancies, improve workflow, better train new clinic staff, and reduce omission errors.

Hingwala J, Komenda P, Tangri N. Quality indicators for the Manitoba Renal Program (MRP). Translating the MRP strategic plan goals to quality indicator measures that are accurate and actionable.

Improving responsiveness across the continuum of kidney health care in rural and remote Manitoba First Nation communities (IKHealth) co-Principal applicants : Dr. Josee Lavoie, Caroline Chartrand, Lorraine McLeod, James Zacharias. CIHR – 5 year funding starting April 1, 2018, $1,575,000.00

Hingwala J, Tangri N, Komenda P, Armstrong S, Paretz D, Cuvelier, S, Peritoneal dialysis catheters for the treatment of refractory ascites management:  A randomized un-blinded pilot study.

Publications

St. Peter WL, Wazny LD, Weinhandl ED. Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies. Am J Kidney Dis 2018;71(2):246-53.

St. Peter WL, Wazny LD, Weinhandl E, Cardone KE, Hudson JQ. A review of phosphate binders in chronic kidney disease: Incremental progress of just higher costs? Drugs 2017, 77(11):1155-86.

Wazny L, Moist L.Ch. 100 Chronic Kidney Disease.  In: Gray, J, ed. Compendium of Therapeutic Choices 2017 ed. Ottawa, ON: Canadian Pharmacists Association, 2017.

Hudson JQ, Wazny LD.  Ch. 44 Chronic Kidney Disease.  In: Dipiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: A Pathophysiologic Approach 10th ed. New York, NY.: McGraw Hill Companies, Inc.; 2017.

St. Peter W., Wazny L, Weinhandl E. FR-PO882 Phosphate binder use and cost trends in US dialysis patients. J Am Soc Nephrol Oct 2017;28(abstract ed):631. American Society of Nephrology (ASN) Annual Meeting, New Orleans, LA (Nov 2-5, 2017).

Hougen I, Collister D, Bourrier M, Ferguson T, Hochheim L, Komenda P, Rigatto C, Tangri N. Safety of Intravenous Iron in  Dialysis: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2018 Mar 7;13(3):457-467. doi: 10.2215/CJN.0539051. Epub 2018 Feb 20. PubMed PMID: 29463597; PubMed Central PMCID: PMC5967668.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR. Perceived Benefits  and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study. Can J Kidney Health Dis. 2018 Mar 23;5:2054358118763809. doi:  0.1177/2054358118763809. eCollection 2018. PubMed PMID: 29636981; PubMed Central PMCID: PMC5888822.

Collister D, Tangri N. Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKD. Kidney Int Rep. 2018 Mar 15;3(3):513-515. doi: 10.1016/j.ekir.2018.02.013. eCollection 2018 May. PubMed PMID: 29854958; PubMed Central PMCID: PMC5976847

Arora RC, Tangri N. All that glitters may not be gold: Changes in serum creatinine may not be the criterion standard for acute kidney injury. J Thorac Cardiovasc Surg. 2018 Jun;155(6):2439-2440. doi: 10.1016/j.jtcvs.2018.01.047. Epub 2018 Feb 8. PubMed PMID: 29530573.

Bohm CJ, Storsley LJ, Hiebert BM, Nelko S, Tangri N, Cheskin LJ, McAdams-DeMarco MA, Rigatto C. Impact of Exercise Counseling on Physical Function in Chronic Kidney Disease: An Observational Study. Can J Kidney Health Dis. 2018

Feb 19;5:2054358117753615. doi: 10.1177/2054358117753615. eCollection 2018. PubMed PMID: 29487746; PubMed Central PMCID: PMC5821295.

Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, Tangri N, Goh SY Thuresson M, Chen H, Surmont F, Hammar N, Fenici P; CVD-REAL Investigators and Study Group. Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other

Glucose-Lowering Drugs: The CVD-REAL 2 Study. J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639. doi: 10.1016/j.jacc.2018.03.009. Epub 2018 Mar 11. PubMed PMID: 29540325.

Harasemiw O, Milks S, Oakley L, Lavallee B, Chartrand C, McLeod L, Di Nella M, Rigatto C, Tangri N, Ferguson T, Komenda P. Remote Dwelling Location Is a Risk Factor for CKD Among Indigenous Canadians. Kidney Int Rep. 2018 Feb 10;3(4):825-832. doi: 10.1016/j.ekir.2018.02.002. eCollection 2018 Jul. PubMed PMID: 29989009; PubMed Central PMCID: PMC6035135.

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C,

Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M,  Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B. Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD):

Form and Function. Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018. PubMed PMID: 29372064; PubMed Central PMCID: PMC5774731.

Wu J, Dong M, Santos S, Rigatto C, Liu Y, Lin F. Lab-on-a-Chip Platforms for  Detection of Cardiovascular Disease and Cancer Biomarkers. Sensors (Basel). 2017  Dec 17;17(12). pii: E2934. doi: 10.3390/s17122934. Review. PubMed PMID: 29258216;

PubMed Central PMCID: PMC5751502.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M1, Ravani P. (2018). Association between Duration of Predialysis Care and Mortality after Dialysis Start.Clin J Am Soc Nephrol.

Zelenitsky SA, Howarth J, Lagacé-Wiens P, Sathianathan C, Ariano R, Davis C, Verrelli M. (2017). Microbiological Trends and Antimicrobial Resistance in Peritoneal Dialysis-Related Peritonitis, 2005 to 2014. Peritoneal Dialysis International 2017 Mar-Apr. 37(2): 170-176.